Close

Supernus Pharma (SUPN) Proposed Private Offering of $350 Million of Convertible Senior Notes

March 13, 2018 4:02 PM EDT Send to a Friend
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) (the “Company”), a specialty pharmaceutical company focused on developing and commercializing products for the treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login